SIONNA THERAPEUTICS, INC. Other Comprehensive Income (Loss), Net of Tax
SIONNA THERAPEUTICS, INC. (SION) reported Other Comprehensive Income (Loss), Net of Tax of -$364.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-06
- SIONNA THERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was -$364.00K.
- SIONNA THERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was -$624.00K.
- SIONNA THERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was $237.00K, a 74.49% decline year-over-year.
- SIONNA THERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-06-30 was -$118.00K.
- SIONNA THERAPEUTICS, INC. other comprehensive income (loss), net of tax for fiscal 2025 was $172.00K, a 53.26% decline from fiscal 2024.
- SIONNA THERAPEUTICS, INC. other comprehensive income (loss), net of tax for fiscal 2024 was $368.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$364.00K 10-Q · filed 2026-08-06 | -$988.00K derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2026-03-31 | -$624.00K 10-Q · filed 2026-08-06 | |||
| 2025-12-31 | $172.00K 10-K · filed 2026-03-02 | |||
| 2025-09-30 | $237.00K 10-Q · filed 2025-11-05 | $119.00K derived: sum of 2 quarters · filed 2026-08-06 | $52.00K derived: sum of 3 quarters · filed 2026-08-06 | |
| 2025-06-30 | -$118.00K 10-Q · filed 2026-08-06 | -$185.00K derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2025-03-31 | -$67.00K 10-Q · filed 2026-08-06 | |||
| 2024-12-31 | $368.00K 10-K · filed 2026-03-02 | |||
| 2024-09-30 | $929.00K 10-Q · filed 2025-11-05 | $781.00K derived: sum of 2 quarters · filed 2025-11-05 | $773.00K derived: sum of 3 quarters · filed 2025-11-05 | |
| 2024-06-30 | -$148.00K 10-Q · filed 2025-11-05 | -$156.00K derived: sum of 2 quarters · filed 2025-11-05 | ||
| 2024-03-31 | -$8.00K 10-Q · filed 2025-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |